# Tempest Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2021

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 10-K/A
- Filed: 2022-04-01
- Accepted by EDGAR: Mar 31, 2022, 21:43 ET
- Period: 2021-12-31
- Accession: 0001193125-22-092417
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000119312522092417/d328059d10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000119312522092417/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000119312522092417/d328059d10ka.htm

Filed Apr 1, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-092417. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
